The oral capsule format is designed for gastrointestinal pharmacology studies investigating local GI effects (gastric ulcer models, IBD models) and systemic bioavailability via the oral route
GLP-1s mimic a hormone your body already makes, but when you start giving it a boost, your digestive system, appetite, and blood sugar regulation are all shifting at once
Synergy was assessed using SynergyFinder 3.0 ( Figures 2A, B )
Riguardo loutcome composito renale, nel gruppo liraglutide lincidenza di nefropatia stata inferiore del 22% rispetto al placebo con un impatto favorevole soprattutto sulla macroalbuminuria, mentre non sono state registrate differenze significative riguardo gli hard endpoints renali
For autoimmune patients already at risk for bone loss, this could be a clinically meaningful distinction when choosing between available GLP-1/GIP medications